Ameritas Investment Partners, Inc. Procept Bio Robotics Corp Transaction History
Ameritas Investment Partners, Inc.
- $3.05 Billion
- Q2 2025
A detailed history of Ameritas Investment Partners, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 5,364 shares of PRCT stock, worth $184,414. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,364
Previous 4,661
15.08%
Holding current value
$184,414
Previous $271,000
13.65%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding PRCT
# of Institutions
289Shares Held
45.3MCall Options Held
236KPut Options Held
91.9K-
Vanguard Group Inc Valley Forge, PA5.25MShares$180 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$120 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.16MShares$74.2 Million0.04% of portfolio
-
Chicago Capital, LLC1.57MShares$53.9 Million1.39% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.53MShares$52.5 Million0.06% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.53B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...